About Core Clinical Solutions

Leveraging our extensive experience and unique perspective to deliver strategic, cost-effective clinical solutions.

Our Story

Core Clinical Solutions was founded on firsthand experience in guiding innovative treatments through development, from concept to approval in the EU and US. We understand the unique challenges start-ups and small businesses face with limited budgets and complex regulations. With over 30 years of combined pharmaceutical development experience, our team recognised this opportunity to make a difference by providing expert project management and strategic guidance.

Meet our management team

Our leadership team combines extensive experience and a shared vision for exceptional clinical research services, driving efficiency and client success.

Chris Roper

Founder + Operations Lead

View LinkedIn Profile

Mark Ellison

Chief Scientific Officer

View LinkedIn Profile

Laura Nachoom-Slagel

Finance Officer

View LinkedIn Profile

Clifton Flack

Marketing Officer

View LinkedIn Profile

Our Collective Commitment

Leveraging expertise in clinical operations, project management, and global pharmaceutical strategy, we deliver projects efficiently while meeting high regulatory standards. Through proactive planning, risk management, and clear communication, we anticipate challenges, maintain timelines, and foster strong partnerships to accelerate innovative therapies to patients. CCS is dedicated to continually expanding our portfolio, enhancing our value as a strategic partner, driving greater success for our clients' projects.

Our Mission

Our mission: provide sponsors with streamlined and cost-effective project management, strategic consultancy, and vendor oversight, with a primary focus on patient interests and developmental needs.

Our Vision

Our vision: be the trusted partner in clinical development, pioneering a streamlined, cost-effective, and patient-centric approach across project management, strategic consultancy, and vendor oversight, consistently advancing safe and effective therapies from concept to market access.

Let's start the conversation